Anagenesis Biotechnologies launches its US subsidiary, Anagenesis Biotherapies Inc. in Boston, Massachusetts to carry out its cell therapy programs

Anagenesis Biotechnologies, a company developing stem cell-derived treatments for muscle diseases, announced the creation of its US subsidiary, Anagenesis Biotherapies Inc. with offices at the Cambridge Innovation Center’s 50 Milk Street facility in Boston, Massachusetts. The US subsidiary will carry out the company’s cell therapy programs with an initial focus on Duchenne Muscular Dystrophy (DMD), paving the way for future partnerships.